- Home
- MRNA vs ONON Comparison
MRNA vs ONON Comparison
Compare MRNA & ONON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- ONON
- Stock Information
- Founded
- MRNA 2010
- ONON 2010
- Country
- MRNA United States
- ONON Switzerland
- Employees
- MRNA N/A
- ONON N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- ONON Shoe Manufacturing
- Sector
- MRNA Health Care
- ONON Consumer Discretionary
- Exchange
- MRNA Nasdaq
- ONON Nasdaq
- Market Cap
- MRNA 16.5B
- ONON 14.8B
- IPO Year
- MRNA 2018
- ONON 2021
- Fundamental
- Price
- MRNA $38.36
- ONON $54.79
- Analyst Decision
- MRNA Hold
- ONON Strong Buy
- Analyst Count
- MRNA 19
- ONON 24
- Target Price
- MRNA $79.50
- ONON $54.70
- AVG Volume (30 Days)
- MRNA 7.7M
- ONON 3.0M
- Earning Date
- MRNA 11-07-2024
- ONON 11-12-2024
- Dividend Yield
- MRNA N/A
- ONON N/A
- EPS Growth
- MRNA N/A
- ONON 55.69
- EPS
- MRNA N/A
- ONON 0.46
- Revenue
- MRNA $5,081,000,000.00
- ONON $2,555,669,993.00
- Revenue This Year
- MRNA N/A
- ONON $31.08
- Revenue Next Year
- MRNA N/A
- ONON $27.46
- P/E Ratio
- MRNA N/A
- ONON $119.88
- Revenue Growth
- MRNA N/A
- ONON 26.12
- 52 Week Low
- MRNA $35.80
- ONON $25.78
- 52 Week High
- MRNA $170.47
- ONON $60.12
- Technical
- Relative Strength Index (RSI)
- MRNA 35.63
- ONON 46.75
- Support Level
- MRNA $41.06
- ONON $56.53
- Resistance Level
- MRNA $44.38
- ONON $58.93
- Average True Range (ATR)
- MRNA 2.57
- ONON 1.85
- MACD
- MRNA 0.16
- ONON -0.52
- Stochastic Oscillator
- MRNA 1.74
- ONON 5.16
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ONON On Holding AG
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa, and Asia-Pacific region.